Choline for cognitive enhancement: what the evidence actually shows

What did @clay.cognitiv actually say?

The creator argues that boosting what they call "SQL calling" (clearly meaning the cholinergic system) improves memory, focus, and synaptic plasticity. They recommend alpha-GPC, something called "rossomes" (likely racetams), "no-fabs" (possibly noopept or related compounds), and nicotine microdoses as ways to increase cholinergic activity. The core argument: better choline signaling equals better learning and sharper focus.

To be fair, the underlying premise is not invented. Acetylcholine is a real neurotransmitter with a well-documented role in attention and memory encoding. The problem is that the video mispronounces, mislabels, and oversimplifies nearly every mechanism it touches, and some of the suggested compounds are either poorly evidenced or carry real risks the creator skips entirely.

Does the science back this up?

The broad strokes are supported by decades of research, but the specifics are where this falls apart. Acetylcholine is genuinely involved in memory and attention, and alpha-GPC does raise acetylcholine levels. The rest gets shaky fast.

Alpha-GPC has the strongest case here. A 2023 study by Marcus et al. in the Journal of the International Society of Sports Nutrition found acute alpha-GPC supplementation improved attention in healthy young adults, though effect sizes were modest. The synaptic plasticity claim is also directionally correct: cholinergic signaling modulates long-term potentiation, a mechanism involved in learning (Hasselmo, 2006, Progress in Brain Research).

"Rossomes" is almost certainly racetams, a class that includes piracetam and aniracetam. The evidence here is genuinely mixed. Most robust trials involve older adults or people with cognitive impairment, not healthy young people. Applying those results to a gym-going TikTok audience is a real stretch. Nicotine microdosing is the most controversial suggestion, and the creator breezes past it without any safety context whatsoever.

What did they get wrong (or right)?

They got the foundation right and built a shaky house on top of it. The cholinergic system does matter for memory and learning. Synaptic plasticity is real and relevant. Alpha-GPC is a reasonably well-studied precursor. Credit where it is due.

But "nicotine microdoses" as a casual recommendation is irresponsible without context. Nicotine is addictive, affects cardiovascular function, and its cognitive benefits in non-smokers are short-term and tolerance-develops quickly (Heishman et al., 2010, Psychopharmacology). Recommending it in a 30-second clip as a brain booster without noting dependence risk is a meaningful omission.

The "rossomes" recommendation is also a problem. If these are racetams, they are not approved by the FDA as supplements. Some are prescription drugs in other countries. The creator presents them as a routine stack item with no regulatory or safety caveat.

• The claim that choline "makes old information more easily accessible" is an oversimplification. Acetylcholine primarily affects encoding and attention, not necessarily retrieval (Hasselmo, 2006).
• "No-fabs" is unidentifiable as a real compound category, which makes fact-checking it impossible.
• Framing nicotine as a routine cognitive enhancer without addiction context is misleading.

What should you actually know?

If you are interested in cholinergic support, alpha-GPC is the compound with the most credible evidence and the most reasonable safety profile for healthy adults. That does not mean it will turn you into a better thinker overnight.

The honest picture: choline supplementation studies in healthy young adults tend to show modest effects at best. The most dramatic results come from populations with choline deficiency or age-related decline (Poly et al., 2011, American Journal of Clinical Nutrition). Many people eating a diet with eggs, liver, or legumes are not choline-deficient to begin with.

Racetams and nicotine carry regulatory and safety considerations that a 30-second TikTok cannot adequately address. Anyone considering compounds outside the standard supplement category should consult a licensed clinician, not a fitness influencer. FormBlends operates as a regulated telehealth platform specifically because these conversations need clinical oversight, not hashtags.

The video's core message, that the cholinergic system matters for cognition, is not wrong. The problem is it packages that real science inside a recommendation list that ranges from reasonable to genuinely risky, with no way for the viewer to tell which is which.